MP09-15 CAN CLINICAL PROSTATE SCORE (CLIPS) BE USED AS A USEFUL ADJUNCT FOR PREDICTING SUCCESS IN MINIMAL INVASIVE SURGICAL THERAPY (MIST) OF THE PROSTATE?

辅助 剪辑 医学 前列腺 外科 内科学 癌症 哲学 语言学
作者
Gregory Pek,Terence Law,Wei Jin Chua,Edmund Chiong,David Consigliere,Woon Tsang
出处
期刊:The Journal of Urology [Ovid Technologies (Wolters Kluwer)]
卷期号:211 (5S)
标识
DOI:10.1097/01.ju.0001008920.55771.18.15
摘要

You have accessJournal of UrologyBenign Prostatic Hyperplasia: Epidemiology, Evaluation & Medical Non-surgical Therapy (MP09)1 May 2024MP09-15 CAN CLINICAL PROSTATE SCORE (CLIPS) BE USED AS A USEFUL ADJUNCT FOR PREDICTING SUCCESS IN MINIMAL INVASIVE SURGICAL THERAPY (MIST) OF THE PROSTATE? Gregory Pek, Terence Law, Wei Jin Chua, Edmund Chiong, David Consigliere, and Woon C. Tsang Gregory PekGregory Pek , Terence LawTerence Law , Wei Jin ChuaWei Jin Chua , Edmund ChiongEdmund Chiong , David ConsigliereDavid Consigliere , and Woon C. TsangWoon C. Tsang View All Author Informationhttps://doi.org/10.1097/01.JU.0001008920.55771.18.15AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: CLIPS is a novel method for predicting bladder outlet obstruction (BOO) without the need for invasive methods such as urodynamics studies.1 CLIPS was used clinically to measure voiding functions for patient going for MIST.2 Ito et al. proposed maximum flow rate (Qmax) and international prostate symptom score (IPSS) as favorable predictive factors to determine prostate surgery outcomes.3 Our aim was to correlate the effectiveness of CLIPS as a useful adjunct for patients going for MIST of the prostate. METHODS: 148 LUTS patients were recruited prospectively for MIST of the prostate (either prostate UroLift or transurethral ablation of prostate (REZUM)) between 2020 to 2022. They were reviewed at 3, 12 and 24 months with assessment of prostate volume (PV), IPSS, Quality of life (QoL) and international index of erectile function (IIEF) questionnaires and uroflow parameters (Qmax, voided volume (VV), post void residual (PVR)). Patients were stratified according to CLIPS; no BOO if 3*Qmax was greater than PV and BOO if 3*Qmax was less than PV. We also examined IPSS changes from baseline after prostate surgery. Analysis was done using student t-test comparing the non-obstructing and obstructing groups. RESULTS: 148 LUTS patients (mean age 64 years) were recruited. Table 1 showed patients stratified according to CLIPS and PV 40 cc as a cut-off. There were significant differences for Qmax and CLIPS at 3, 12 and 24 months (p<0.0001) between the 2 groups. VV was much better for patients with PV <40 cc and in those with no BOO. There was significant IPSS improvement using IPSS 16 as a cut-off between the 2 groups at 3 months (IPSS<16: -11.15±6.79 and 4.50±10.73, p<0.0001 vs IPSS >16: -8.23±9.95 and 3.83±9.24, p=0.00095), 12 months (IPSS <16: -11.12±6.08 and -0.40±2.97, p=0.0007 vs IPSS >16: -6.86±8.84 and 2.88±11.48, p=0.00111) and 24 months (IPSS <16: -6.79±9.31 and 0.71±3.55, p=0.0558 vs IPSS >16: -12.18±5.08 and 2.14±8.24, p=0.0003). Patients had IPSS improvement of 81.2% at 3 months, 85.5% at 12 months and 80.8% at 24 months if IPSS <16 respectively and worsening symptoms of 50% at 3 months, 23.1% at 12 months and 57.1% at 24 months if IPSS >16. CONCLUSIONS: CLIPS can be used to predict possible outcome of MIST especially using Qmax and changes in IPSS score. Prostate <40 cc and IPSS <16 have better surgical outcome compared to larger prostates and IPSS >16. A larger study would be needed to validate this. References: 1. Rosier et al. ICS 2022; 2. Tsang et al. AUA 2023; 3. Ito et al. European Urology Focus 2023. Source of Funding: None © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e132 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Gregory Pek More articles by this author Terence Law More articles by this author Wei Jin Chua More articles by this author Edmund Chiong More articles by this author David Consigliere More articles by this author Woon C. Tsang More articles by this author Expand All Advertisement PDF downloadLoading ...
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
肥肥的呢完成签到,获得积分10
3秒前
感谢zhuhmed转发科研通微信,获得积分50
4秒前
4秒前
辣椒小皇纸完成签到 ,获得积分10
5秒前
Creamai发布了新的文献求助10
6秒前
感谢xiang9转发科研通微信,获得积分50
8秒前
8秒前
华仔应助liujinjin采纳,获得10
8秒前
小蘑菇应助云轩采纳,获得10
8秒前
星辰大海应助浮世采纳,获得10
10秒前
羊大侠完成签到,获得积分10
10秒前
2531完成签到,获得积分10
11秒前
11秒前
感谢zzz转发科研通微信,获得积分50
12秒前
新一完成签到 ,获得积分10
12秒前
DrZOU完成签到,获得积分10
13秒前
勤奋靖易发布了新的文献求助100
13秒前
风起人散完成签到,获得积分10
14秒前
shinysparrow应助羊大侠采纳,获得10
14秒前
14秒前
千幻完成签到,获得积分10
16秒前
感谢lanjl转发科研通微信,获得积分50
16秒前
Akim应助研友_LweedZ采纳,获得10
16秒前
Echo完成签到,获得积分10
19秒前
感谢猕猴桃转发科研通微信,获得积分50
20秒前
21秒前
Jasper应助2531采纳,获得10
22秒前
24秒前
感谢妧素衣转发科研通微信,获得积分50
24秒前
希望天下0贩的0应助Jason采纳,获得10
25秒前
DrZOU发布了新的文献求助10
27秒前
yydcmnyxx完成签到,获得积分20
27秒前
Creamai完成签到,获得积分10
27秒前
勤奋靖易完成签到,获得积分10
28秒前
Kenny完成签到,获得积分10
31秒前
一次性过完成签到 ,获得积分10
32秒前
肥羊七号完成签到 ,获得积分10
33秒前
frank完成签到 ,获得积分10
34秒前
34秒前
高分求助中
请在求助之前详细阅读求助说明!!!! 20000
Sphäroguß als Werkstoff für Behälter zur Beförderung, Zwischen- und Endlagerung radioaktiver Stoffe - Untersuchung zu alternativen Eignungsnachweisen: Zusammenfassender Abschlußbericht 1500
One Man Talking: Selected Essays of Shao Xunmei, 1929–1939 1000
Yuwu Song, Biographical Dictionary of the People's Republic of China 700
[Lambert-Eaton syndrome without calcium channel autoantibodies] 520
The Three Stars Each: The Astrolabes and Related Texts 500
A radiographic standard of reference for the growing knee 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2469397
求助须知:如何正确求助?哪些是违规求助? 2136519
关于积分的说明 5443918
捐赠科研通 1860985
什么是DOI,文献DOI怎么找? 925582
版权声明 562702
科研通“疑难数据库(出版商)”最低求助积分说明 495140